SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-15-024949
Filing Date
2015-04-24
Accepted
2015-04-24 16:05:35
Documents
5
Period of Report
2015-06-04
Effectiveness Date
2015-04-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A v408055_def14a.htm DEF 14A 347619
2 GRAPHIC proxy2.jpg GRAPHIC 83629
3 GRAPHIC proxycard11.jpg GRAPHIC 73380
4 GRAPHIC proxycard22.jpg GRAPHIC 96726
5 GRAPHIC tlogo.jpg GRAPHIC 13060
  Complete submission text file 0001144204-15-024949.txt   717089
Mailing Address 787 SEVENTH AVENUE NEW YORK NY 10019
Business Address 787 SEVENTH AVENUE NEW YORK NY 10019 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-32639 | Film No.: 15791854
SIC: 2834 Pharmaceutical Preparations